Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (101-110 of 792) with videos related to

Pageof 80
Sort By:
Current Opinion in Critical Care|September 13, 2008
The use of natriuretic peptides in the intensive care unitRomain Pirracchio, Damien Logeart, Markus Noveanu, et al.
Clinical Chemistry|June 17, 2015
Unraveling N-terminal pro-B-type natriuretic peptide: another piece to a very complex puzzle in heart failure patientsAllan S Jaffe, Fred S Apple, Alexandre Mebazaa, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Novel insights into microcirculatory dysfunction in cardiogenic shockHamid Merdji, Anaïs Curtiaud, Clément Delmas, et al.
Anaesthesia, Critical Care & Pain Medicine|December 24, 2021
Inotropes and vasopressors are associated with increased short-term mortality but not long-term survival in critically ill patientsJustina Motiejunaite, Benjamin Deniau, Alice Blet, et al.
European Journal of Heart Failure|August 25, 2017
RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure researchGad Cotter, Alain Cohen-Solal, Beth A Davison, et al.
European Heart Journal|July 31, 2018
Plasma neprilysin concentration during recovery from acute illnessMattia Arrigo, Hélène Nougué, Jean-Marie Launay, et al.
Archives of Gerontology and Geriatrics|September 10, 2016
Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patientsAntonio Teixeira, Mattia Arrigo, Giuseppe Vergaro, et al.
Journal of Clinical Anesthesia|February 8, 2022
Which dose of ketamine to use for rapid sequence intubation in critically ill patients in hemodynamic shock?Romain Barthélémy, Victor Beaucoté, Etienne Gayat, et al.
European Journal of Heart Failure|December 15, 2022
Targeting the 'vulnerable' period - first 3-6 months after an acute heart failure admission - the light gets brighterGad Cotter, Beth Davison, Alain Cohen-Solal, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2025
Why Molecular Subphenotyping Is Needed in Cardiogenic Shock and How to Accomplish ThisSabri Soussi, Susanna Price, Alastair Proudfoot, et al.
Pageof 80

Showing results (101-110 of 792) with videos related to

Sort By:
Pageof 80
Current Opinion in Critical Care|September 13, 2008
The use of natriuretic peptides in the intensive care unitRomain Pirracchio, Damien Logeart, Markus Noveanu, et al.
Clinical Chemistry|June 17, 2015
Unraveling N-terminal pro-B-type natriuretic peptide: another piece to a very complex puzzle in heart failure patientsAllan S Jaffe, Fred S Apple, Alexandre Mebazaa, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Novel insights into microcirculatory dysfunction in cardiogenic shockHamid Merdji, Anaïs Curtiaud, Clément Delmas, et al.
Anaesthesia, Critical Care & Pain Medicine|December 24, 2021
Inotropes and vasopressors are associated with increased short-term mortality but not long-term survival in critically ill patientsJustina Motiejunaite, Benjamin Deniau, Alice Blet, et al.
European Journal of Heart Failure|August 25, 2017
RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure researchGad Cotter, Alain Cohen-Solal, Beth A Davison, et al.
European Heart Journal|July 31, 2018
Plasma neprilysin concentration during recovery from acute illnessMattia Arrigo, Hélène Nougué, Jean-Marie Launay, et al.
Archives of Gerontology and Geriatrics|September 10, 2016
Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patientsAntonio Teixeira, Mattia Arrigo, Giuseppe Vergaro, et al.
Journal of Clinical Anesthesia|February 8, 2022
Which dose of ketamine to use for rapid sequence intubation in critically ill patients in hemodynamic shock?Romain Barthélémy, Victor Beaucoté, Etienne Gayat, et al.
European Journal of Heart Failure|December 15, 2022
Targeting the 'vulnerable' period - first 3-6 months after an acute heart failure admission - the light gets brighterGad Cotter, Beth Davison, Alain Cohen-Solal, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2025
Why Molecular Subphenotyping Is Needed in Cardiogenic Shock and How to Accomplish ThisSabri Soussi, Susanna Price, Alastair Proudfoot, et al.
Pageof 80